A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients
Haemophilia · 2023
DOI: 10.1111/hae.14802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haemophilia, 2023. Verfasst von Philippe de Mazancourt und 12 weiteren Autor:innen. Beteiligte Einrichtung: UMR1179, Université de Versailles-Saint-Quentin, Montigny le Bretonneux, France. Hauptthemen laut MEDLINE: Factor XI, Factor XI Deficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Versailles-St-Quentin, Assistance Publique-Hôpitaux de Paris.
Abstract (Originalsprache)
Introduction
Dominant‐negative effects have been described for 10 F11 variants in the literature.
Aim
The current study aimed at identifying putative dominant‐negative F11 variants. Material and methods This research consisted in a retrospective analysis of routine laboratory data.
Results
In a series of 170 patients with moderate/mild factor XI (FXI) deficiencies, we identified heterozygous carriers of previously reported dominant‐negative variants (p.Ser243Phe, p.Cys416Tyr, and p.Gly418Val) with FXI activities inconsistent with a dominant‐negative effect. Our findings also do not support a dominant‐negative effect of p.Gly418Ala. We also identified a set of patients carrying heterozygous variants, among which five out of 11 are novel, with FXI activities suggesting a dominant‐negative effect (p.His53Tyr, p.Cys110Gly, p.Cys140Tyr, p.Glu245Lys, p.Trp246Cys, p.Glu315Lys, p.Ile421Thr, p.Trp425Cys, p.Glu565Lys, p.Thr593Met, and p.Trp617Ter). However, for all but two of these variants, individuals with close to half normal FXI coagulant activity (FXI:C) were identified, indicating an inconstant dominant effect.
Conclusion
Our data show that for some F11 variants recognized has having dominant‐negative effects, such effects actually do not occur in many individuals. The present data suggest that for these patients, the intracellular quality control mechanisms eliminate the variant monomeric polypeptide before homodimer assembly, thereby allowing only the wild‐type homodimer to assemble and resulting in half normal activities. In contrast, in patients with markedly decreased activities, some mutant polypeptides might escape this first quality control. In turn, assembly of heterodimeric molecules as well as mutant homodimers would result in activities closer to 1:4 of FXI:C normal range.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UMR1179, Université de Versailles-Saint-Quentin, Montigny le Bretonneux, France.
- Laboratoire de Biologie Moléculaire, Hôpital A. Paré, APHP.Paris-Saclay, Boulogne-Billancourt, France.
- Département de Recherche Clinique, CH Versailles, Le Chesnay, France.
- Laboratoire de biologie médicale, secteur hémostase, centre hospitalier de Versailles (André Mignot), Le Chesnay, France.
- Centre de Ressources et de Compétences Maladies Hémorragiques Constitutionnelles, CH de Versailles, Le Chesnay, France.
- Centre de Traitement des maladies hémorragiques, Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.
ORCID-Profile: Philippe de Mazancourt, Emmanuelle de Raucourt, Benoît Guillet, Roseline d'Oiron, Christine Biron-Andréani
Förderung
- University of Versailles-St-Quentin
- Assistance Publique-Hôpitaux de Paris
Zitieren
APA
de Mazancourt, P., Quélin, F., Flaujac, C., de Raucourt, E., Guillet, B., Bauduer, F., Ernest, V., Beurrier, P., Avril, A., d'Oiron, R., Biron-Andréani, C., Meunier, S., & Dargaud, Y. (2023). A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients. Haemophilia. https://doi.org/10.1111/hae.14802
Vancouver
de Mazancourt P, Quélin F, Flaujac C, de Raucourt E, Guillet B, Bauduer F, et al. A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients. Haemophilia. 2023. doi:10.1111/hae.14802
BibTeX
@article{deMazancourt2023,
author = {de Mazancourt, Philippe and Quélin, Florence and Flaujac, Claire and de Raucourt, Emmanuelle and Guillet, Benoît and Bauduer, Frédéric and Ernest, Vincent and Beurrier, Philippe and Avril, Aurélie and d'Oiron, Roseline and Biron-Andréani, Christine and Meunier, Sandrine and Dargaud, Yesim},
title = {A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients},
journal = {Haemophilia},
year = {2023},
doi = {10.1111/hae.14802}
}
EUVIMED